Does Day One Biopharmaceuticals Inc (DAWN) Have What it Takes to be in Your Portfolio Thursday?

Thursday, September 15, 2022 02:25 PM | InvestorsObserver Analysts

Mentioned in this article

The 70 rating InvestorsObserver gives to Day One Biopharmaceuticals Inc (DAWN) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 79 percent of stocks in the Biotechnology industry, DAWN’s 70 overall rating means the stock scores better than 70 percent of all stocks.

DAWN has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on DAWN!
See Full DAWN Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 70 means the stock is more attractive than 70 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Day One Biopharmaceuticals Inc Stock Today?

Day One Biopharmaceuticals Inc (DAWN) stock is trading at $22.89 as of 2:23 PM on Thursday, Sep 15, a decline of -$0.43, or -1.84% from the previous closing price of $23.32. The stock has traded between $22.28 and $24.11 so far today. Volume today is below average. So far 293,048 shares have traded compared to average volume of 642,126 shares. Click Here to get the full Stock Report for Day One Biopharmaceuticals Inc stock.

Share this article:

Related Articles